On-line Education Teaches Physicians About Multiple Sclerosis

OSUWexnerbloglogo2014 On-line Education Teaches Physicians About Multiple Sclerosis. Over the past 25 years, there have been dramatic new developments in how we treat multiple sclerosis and this is giving hope to patients who on the past had very few options. Here today to bring us up to date on the latest developments in multiple sclerosis is the Chairman of the OSU Department of Neurology, Dr. Benjamin Segal.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: LEARN about the typicalclinical course of multiple sclerosis and disease modifying treatments; and LEARN about our current understanding of the pathogenesis of MS.

You’ll also learn about the following:

  • Common signs and symptoms of multiple sclerosis
  • Current concepts in multiple sclerosis treatment

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Education Teaches Physicians About Interstitial Lung Disease

OSUWexnerbloglogo2014 On-line Education Teaches Physicians About Interstitial Lung Disease. Once each year, I exercise moderator’s privileges and serve as both host and presenter and so today, I’m going to be talking about a topic that is important to me, namely interstitial lung disease.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: IDENTIFY patients with undiagnosed interstitial lung disease based on clinical, radiographic, and pulmonary function test presentations; DISTINGUISH idiopathic pulmonary fibrosis from other common interstitial diseases based on radiographic and pathologic findings; and DESCRIBE the initial management of common interstitial lung diseases including idiopathic pulmonary fibrosis, non-specific interstitial pneumonitis,
hypersensitivity pneumonitis, and sarcoidosis.

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Educates Learners on Lung Cancer Staging

OSUWexnerbloglogo2014 CME Webcast Educates Learners on Lung Cancer Staging. On this program, we’re going to update you on the approach to lung cancer staging. Joining on moderator is our lung cancer expert from the Division of Hematology and Medical Oncology, Clinical Instructor of Internal Medicine, Dr. Jean Bustamante Alvarez.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: RECOGNIZE the importance of lung cancer staging and the need for a multidisciplinary approach; and IDENTIFY the minimally necessary studies that will be necessary to stage a patient with lung cancer.

You’ll also learn about the following:

  • Racial disparities in lung cancer diagnosis and survival
  • Staging small cell lung cancer
  • Surgery versus stereotactic ablative radiotherapy
  • Stereotactic ablative radiotherapy
  • When PET-CT can miss lung cancer

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Lung Diseases They Didn’t Teach You About in Medical School

OSUWexnerbloglogo2014 Lung Diseases They Didn’t Teach You About in Medical School. On this CME webcast, we’re going to talk about 10 lung diseases that you probably didn’t learn about in medical school, either because they weren’t discovered at the time, we didn’t have good tests for at the time, or their importance wasn’t known about at the time.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DIAGNOSE and treat recently discovered genetic lung diseases; and DIAGNOSE and treat uncommon pulmonary infections.

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Discusses New Therapies for Lung Cancer

OSUWexnerbloglogo2014 CME Webcast Discusses New Therapies for Lung Cancer. On this CME webcast, we’re going to update you on the medical management of lung cancer and focus on non-small cell lung cancer. Joining our moderator in the studio is medical oncologist at the James Cancer Hospital and Professor of Internal Medicine from the Ohio State University, Dr. David Carbone.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Review some of the latest practice-changing findings in the management of lung cancer; and Understand the basic principles of workup and initial lung cancer management decisions.

You’ll also learn about the following:

  • Classifying non-small cell lung cancer
  • Common side effects of driver-targeted therapies
  • What the primary care physician needs to know about co-managing patients taking driver-targeted therapy

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.